Secondary Logo

Journal Logo

April 2020 - Volume 41 - Issue 4
pp: 297-410

Three years’ clinical practice of Radium-223 therapy in patients with symptomatic bone metastases from metastatic castrate-resistant prostate cancer: a single-centre experience

Gazzilli, Maria; Durmo, Rexhep; Cossalter, Erika; More

Nuclear Medicine Communications. 41(4):300-307, April 2020.

Iodine-131 metaiodobenzylguanidine (131I-mIBG) treatment in relapsed/refractory neuroblastoma

Anongpornjossakul, Yoch; Sriwatcharin, Wattanun; Thamnirat, Kanungnij; More

Nuclear Medicine Communications. 41(4):336-343, April 2020.

Early detection of progressive disease using thyroglobulin doubling-time in metastatic differentiated thyroid carcinoma treated with radioactive iodine

Zhang, Xieyi; Higuchi, Tetsuya; Tomonaga, Hiroyasu; More

Nuclear Medicine Communications. 41(4):350-355, April 2020.

Textural analysis of hybrid DOTATOC-PET/MRI and its association with histological grading in patients with liver metastases from neuroendocrine tumors

Weber, Manuel; Kessler, Lukas; Schaarschmidt, Benedikt; More

Nuclear Medicine Communications. 41(4):363-369, April 2020.